Back
Hormel Foods 10K Form
Sell
39
HRL
Hormel Foods
Last Price:
30.35
Seasonality Move:
5.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-30 | 10Q | HRL/Hormel Foods Quarterly |
| 2024-02-29 | 10Q | HRL/Hormel Foods Quarterly |
| 2023-12-06 | 10K | HRL/Hormel Foods Annual |
| 2023-08-31 | 10Q | HRL/Hormel Foods Quarterly |
| 2023-06-01 | 10Q | HRL/Hormel Foods Quarterly |
| 2023-03-02 | 10Q | HRL/Hormel Foods Quarterly |
Receive HRL News And Ratings
See the #1 stock for the next 7 days that we like better than HRL
HRL Financial Statistics
Sales & Book Value
| Annual Sales: | $12.11B |
|---|---|
| Cash Flow: | $152.51M |
| Price / Cash Flow: | 17.86 |
| Annual Sales: | $14.35 |
| Price / Book: | 2.05 |
Profitability
| EPS (TTM): | 1.42000 |
|---|---|
| Net Income (TTM): | $780.78M |
| Gross Margin: | $2B |
| Return on Equity: | 9.99% |
| Return on Assets: | 5.77% |
Hormel Foods Earnings Forecast
Key Hormel Foods Financial Ratios
- The Gross Profit Margin over the past 40 years for HRL is 16.51%.
- The Selling, General & Administrative Expenses for HRL have been equal to 7.78% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 9.25% of Operating Income.
- The Net Earning history of HRL is 6.55% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 29 years.
Hormel Foods Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Food Products |
| Sector: | Consumer Staples |
| Current Symbol: | HRL |
| CUSIP: | 440452 |
| Website: | hormelfoods.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 2.29 |
| Quick Ratio: | 0.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.28 |
|---|---|
| Forward P/E Ratio: | 15.8 |
HRL Technical Analysis vs Fundamental Analysis
Sell
39
Hormel Foods (HRL)
is a Sell
Is Hormel Foods a Buy or a Sell?
-
Hormel Foods stock is rated a Sell
The current Hormel Foods [HRL] share price is $30.22. The Score for HRL is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.